Statements (90)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:ceo |
Stephen A. Isaacs
|
| gptkbp:collaborated_with |
Academic institutions
Healthcare organizations Healthcare providers Industry leaders Regulatory bodies Clinical research organizations Biotech firms |
| gptkbp:collaborates_with |
Various pharmaceutical companies
|
| gptkbp:develops |
gptkb:ADU-S100
Therapeutic vaccines |
| gptkbp:focuses_on |
gptkb:Research_and_development
gptkb:Cancer_Immunotherapy Patient outcomes Innovative therapies Novel drug candidates Clinical excellence Therapeutic innovation Patient-centric solutions |
| gptkbp:founded |
gptkb:2014
|
| gptkbp:has_part |
gptkb:Aduro_Biotech,_Inc.
Marketing team Quality assurance team Laboratory facilities Clinical research team Strategic planning team Business development team Data analysis team Regulatory affairs team Data management team Regulatory compliance team Clinical operations team Patient safety team Clinical operations management team Clinical trial management team Patient recruitment team Clinical development programs Research and Development team Clinical strategy team Clinical trial oversight team |
| gptkbp:headquarters |
gptkb:Switzerland
|
| https://www.w3.org/2000/01/rdf-schema#label |
Aduro Biotech Switzerland
|
| gptkbp:is_active_in |
gptkb:International_collaborations
Research funding Clinical research International markets Global health initiatives Global collaborations |
| gptkbp:is_engaged_in |
Market research
Patient support programs Drug development Partnerships with research institutions Patient engagement initiatives Clinical evaluations |
| gptkbp:is_involved_in |
Regulatory affairs
Therapeutic development Patient advocacy Regulatory submissions Clinical trial design Biopharmaceutical development Patient care initiatives Clinical trial recruitment Therapeutic research Clinical data analysis |
| gptkbp:is_known_for |
Research publications
Patient-centered research Innovative cancer treatments Innovative research methodologies Innovative cancer therapies STING pathway Innovative clinical approaches |
| gptkbp:is_part_of |
gptkb:Aduro_Biotech,_Inc.
|
| gptkbp:is_recognized_for |
Scientific contributions
Cutting-edge research Innovative treatment options Collaboration with scientists Scientific research contributions Therapeutic advancements |
| gptkbp:is_supported_by |
Funding from investors
Scientific advisory board |
| gptkbp:located_in |
gptkb:Lausanne
|
| gptkbp:offers |
Clinical trials
|
| gptkbp:operates_in |
Global market
|
| gptkbp:receives_funding_from |
Venture capital
|
| gptkbp:research_focus |
gptkb:healthcare_organization
|
| gptkbp:stock_exchange |
gptkb:battle
|
| gptkbp:utilizes |
Immune system modulation
|
| gptkbp:bfsParent |
gptkb:Aduro_Biotech,_Inc.
|
| gptkbp:bfsLayer |
5
|